Zobrazeno 1 - 10
of 1 847
pro vyhledávání: '"Thompson LC"'
Autor:
Park CH; Environmental Influences on Child Health Outcomes (ECHO) Program, Office of the Director, National Institutes of Health, Bethesda, MD 20852, United States., Blaisdell CJ; Environmental Influences on Child Health Outcomes (ECHO) Program, Office of the Director, National Institutes of Health, Bethesda, MD 20852, United States., Arteaga SS; Environmental Influences on Child Health Outcomes (ECHO) Program, Office of the Director, National Institutes of Health, Bethesda, MD 20852, United States., Mash C; Environmental Influences on Child Health Outcomes (ECHO) Program, Office of the Director, National Institutes of Health, Bethesda, MD 20852, United States., Laessig S; Environmental Influences on Child Health Outcomes (ECHO) Program, Office of the Director, National Institutes of Health, Bethesda, MD 20852, United States., Hanspal M; Environmental Influences on Child Health Outcomes (ECHO) Program, Office of the Director, National Institutes of Health, Bethesda, MD 20852, United States., Luetkemeier E; Environmental Influences on Child Health Outcomes (ECHO) Program, Office of the Director, National Institutes of Health, Bethesda, MD 20852, United States., Thompson LC; Environmental Influences on Child Health Outcomes (ECHO) Program, Office of the Director, National Institutes of Health, Bethesda, MD 20852, United States., Gillman MW; Environmental Influences on Child Health Outcomes (ECHO) Program, Office of the Director, National Institutes of Health, Bethesda, MD 20852, United States.
Publikováno v:
American journal of epidemiology [Am J Epidemiol] 2024 Sep 03; Vol. 193 (9), pp. 1219-1223.
Autor:
Cevik M; Division of Infection and Global Health Research, School of Medicine, University of St Andrews, St Andrews, UK. Electronic address: mc349@st-andrews.ac.uk., Thompson LC; MRC Clinical Trials Unit, University College London, London, UK., Upton C; TASK, Cape Town, South Africa., Rolla VC; Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro, Brazil., Malahleha M; Setshaba Research Centre, Soshanguve, South Africa., Mmbaga B; Kilimanjaro Clinical Research Institute, Moshi, Tanzania., Ngubane N; CHRU, King Dinuzulu, Durban, South Africa., Abu Bakar Z; Institut Perubatan Respiratori, Kuala Lumpur, Malaysia., Rassool M; CHRU, Helen Joseph Hospital, Johannesburg, South Africa., Variava E; PHRU, Tshepong Hospital, Klerksdorp, South Africa., Dawson R; University of Cape Town Lung Institute, Cape Town, South Africa., Staples S; THINK, Durban, South Africa., Lalloo U; Enhancing Care Foundation, Durban, South Africa., Louw C; Madibeng Centre for Research, Brits, South Africa., Conradie F; Reproductive Health and HIV Research Unit (RHRU), University of the Witwatersrand, Johannesburg, South Africa., Eristavi M; National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia., Samoilova A; Research Institute of Phthisiopulmonology of IM Sechenov First Moscow State Medical University, Moscow, Russia., Skornyakov SN; Ural Research Institute for Phthisiopulmonology, National Medical Research Center of Tuberculosis and Infectious Diseases of Ministry of Health of the Russian Federation, Yekaterinburg, Russia., Ntinginya NE; NIMR-Mbeya, Mbeya, Tanzania., Haraka F; Ifakara Health Institute, Ifakara, Tanzania., Praygod G; Mwanza Intervention Trials Unit, Mwanza, Tanzania., Mayanja-Kizza H; Case Western Reserve University, Kampala, Uganda., Caoili J; Tropical Disease Foundation, Makati City, Manila, Philippines., Balanag V; Lung Center of Philippines, Manila, Philippines., Dalcolmo MP; FIOCRUZ, Rio de Janeiro, Brazil., McHugh T; UCL Centre for Clinical Microbiology, University College London, London, UK., Hunt R; UCL Centre for Clinical Microbiology, University College London, London, UK., Solanki P; UCL Centre for Clinical Microbiology, University College London, London, UK., Bateson A; UCL Centre for Clinical Microbiology, University College London, London, UK., Crook AM; MRC Clinical Trials Unit, University College London, London, UK., Fabiane S; MRC Clinical Trials Unit, University College London, London, UK., Timm J; TB Alliance, New York, NY, USA., Sun E; TB Alliance, New York, NY, USA., Spigelman M; TB Alliance, New York, NY, USA., Sloan DJ; Division of Infection and Global Health Research, School of Medicine, University of St Andrews, St Andrews, UK., Gillespie SH; Division of Infection and Global Health Research, School of Medicine, University of St Andrews, St Andrews, UK.
Publikováno v:
The Lancet. Infectious diseases [Lancet Infect Dis] 2024 Sep; Vol. 24 (9), pp. 1003-1014. Date of Electronic Publication: 2024 May 17.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Arenas-Pinto A; Medical Research Council Clinical Trials Unit at University College London, London, United Kingdom.; Centre for Clinical Research in Infection and Sexual Health, University College London Institute for Global Health, London, United Kingdom., Judd A; Medical Research Council Clinical Trials Unit at University College London, London, United Kingdom., Melvin D; Imperial College Healthcare and Central North West London National Health Service Trust, London, United Kingdom., Le Prevost M; Medical Research Council Clinical Trials Unit at University College London, London, United Kingdom., Foster C; Imperial College Healthcare and Central North West London National Health Service Trust, London, United Kingdom., Sturgeon K; Medical Research Council Clinical Trials Unit at University College London, London, United Kingdom., Winston A; Imperial College London, London, United Kingdom., Thompson LC; Medical Research Council Clinical Trials Unit at University College London, London, United Kingdom., Gibb DM; Medical Research Council Clinical Trials Unit at University College London, London, United Kingdom., Castro H; Medical Research Council Clinical Trials Unit at University College London, London, United Kingdom.
Publikováno v:
PloS one [PLoS One] 2022 Sep 15; Vol. 17 (9), pp. e0273645. Date of Electronic Publication: 2022 Sep 15 (Print Publication: 2022).
Autor:
Powers TW; Analytical Research and Development, Biotherapeutic Pharmaceutical Sciences, Pfizer Inc., Chesterfield, MO, United States., Mullins EK; Analytical Research and Development, Biotherapeutic Pharmaceutical Sciences, Pfizer Inc., Chesterfield, MO, United States., Zhang K; Analytical Research and Development, Biotherapeutic Pharmaceutical Sciences, Pfizer Inc., Chesterfield, MO, United States., Binder JJ; Cancer Vaccines and Immunotherapeutics, Pfizer Inc., San Diego, CA, United States., Friese O; Analytical Research and Development, Biotherapeutic Pharmaceutical Sciences, Pfizer Inc., Chesterfield, MO, United States., Runnels HA; Analytical Research and Development, Biotherapeutic Pharmaceutical Sciences, Pfizer Inc., Chesterfield, MO, United States., Thompson LC; Analytical Research and Development, Biotherapeutic Pharmaceutical Sciences, Pfizer Inc., Chesterfield, MO, United States.
Publikováno v:
Frontiers in bioengineering and biotechnology [Front Bioeng Biotechnol] 2022 Apr 05; Vol. 10, pp. 753481. Date of Electronic Publication: 2022 Apr 05 (Print Publication: 2022).
Autor:
Mellin J; Gravitational Physiology and Medicine Research Unit, Division of Physiology, Otto Loewi Research Center, Medical University of Graz, Graz, Austria., Le Prevost M; Medical Research Council Clinical Trials Unit at University College London, London, United Kingdom., Kenny J; Guy's and St. Thomas' National Heath Service Foundation Trust, Evelina London Children's Hospital, St. Thomas' Hospital, London, United Kingdom., Sturgeon K; Medical Research Council Clinical Trials Unit at University College London, London, United Kingdom., Thompson LC; Medical Research Council Clinical Trials Unit at University College London, London, United Kingdom., Foster C; Imperial College Healthcare National Heath Service Trust, St. Mary's Hospital, London, United Kingdom., Kessler HH; Diagnostic and Research Institute of Hygiene, Microbiology, and Environmental Medicine, Medical University of Graz, Graz, Austria., Goswami N; Gravitational Physiology and Medicine Research Unit, Division of Physiology, Otto Loewi Research Center, Medical University of Graz, Graz, Austria.; Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates., Klein N; Department of Infection, Immunity and Inflammation, University College London Great Ormond Street Institute of Child Health, London, United Kingdom., Judd A; Medical Research Council Clinical Trials Unit at University College London, London, United Kingdom., Castro H; Medical Research Council Clinical Trials Unit at University College London, London, United Kingdom.
Publikováno v:
Frontiers in cardiovascular medicine [Front Cardiovasc Med] 2022 Mar 01; Vol. 9, pp. 821568. Date of Electronic Publication: 2022 Mar 01 (Print Publication: 2022).
Autor:
Mullins EK; Analytical Research and Development, Biotherapeutic Pharmaceutical Sciences, Pfizer Inc., Chesterfield, MO, United States., Powers TW; Analytical Research and Development, Biotherapeutic Pharmaceutical Sciences, Pfizer Inc., Chesterfield, MO, United States., Zobel J; Analytical Research and Development, Biotherapeutic Pharmaceutical Sciences, Pfizer Inc., Chesterfield, MO, United States., Clawson KM; Analytical Research and Development, Biotherapeutic Pharmaceutical Sciences, Pfizer Inc., Chesterfield, MO, United States., Barnes LF; Chemistry Department, Indiana University, Bloomington, IN, United States., Draper BE; Megadalton Solutions, Bloomington, IN, United States., Zou Q; Analytical Research and Development, Biotherapeutic Pharmaceutical Sciences, Pfizer Inc., Chesterfield, MO, United States., Binder JJ; Cancer Vaccines and Immunotherapies, Pfizer Inc., San Diego, CA, United States., Dai S; Nektar Therapeutics, San Francisco, CA, United States., Zhang K; Analytical Research and Development, Biotherapeutic Pharmaceutical Sciences, Pfizer Inc., Chesterfield, MO, United States., Friese O; Analytical Research and Development, Biotherapeutic Pharmaceutical Sciences, Pfizer Inc., Chesterfield, MO, United States., Runnels HA; Analytical Research and Development, Biotherapeutic Pharmaceutical Sciences, Pfizer Inc., Chesterfield, MO, United States., Jarrold MF; Chemistry Department, Indiana University, Bloomington, IN, United States., Thompson LC; Analytical Research and Development, Biotherapeutic Pharmaceutical Sciences, Pfizer Inc., Chesterfield, MO, United States.
Publikováno v:
Frontiers in bioengineering and biotechnology [Front Bioeng Biotechnol] 2021 Nov 04; Vol. 9, pp. 753480. Date of Electronic Publication: 2021 Nov 04 (Print Publication: 2021).
Autor:
Thompson LC; Environmental influences on Child Health Outcomes, Office of the Director, National Institutes of Health, North Bethesda, MD, USA., Hall KL; Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, USA., Vogel AL; Office of Policy, Communications and Education, National Center for Advancing Translational Sciences, Bethesda, MD, USA., Park CH; Environmental influences on Child Health Outcomes, Office of the Director, National Institutes of Health, North Bethesda, MD, USA., Gillman MW; Environmental influences on Child Health Outcomes, Office of the Director, National Institutes of Health, North Bethesda, MD, USA.
Publikováno v:
Journal of clinical and translational science [J Clin Transl Sci] 2021 Jun 14; Vol. 5 (1), pp. e139. Date of Electronic Publication: 2021 Jun 14 (Print Publication: 2021).
Autor:
Snow SJ; Public Health and Integrated Toxicology Division, Center for Public Health and Environmental Assessment, U.S. Environmental Protection Agency, Research Triangle Park, North Carolina, United States., Henriquez AR; Oak Ridge Institute for Science and Education Research Participation Program, U.S. Environmental Protection Agency, Research Triangle Park, North Carolina, United States., Thompson LC; Public Health and Integrated Toxicology Division, Center for Public Health and Environmental Assessment, U.S. Environmental Protection Agency, Research Triangle Park, North Carolina, United States., Fisher C; School of Public Health, University of North Carolina, Chapel Hill, North Carolina, United States., Schladweiler MC; Public Health and Integrated Toxicology Division, Center for Public Health and Environmental Assessment, U.S. Environmental Protection Agency, Research Triangle Park, North Carolina, United States., Wood CE; Public Health and Integrated Toxicology Division, Center for Public Health and Environmental Assessment, U.S. Environmental Protection Agency, Research Triangle Park, North Carolina, United States., Kodavanti UP; Public Health and Integrated Toxicology Division, Center for Public Health and Environmental Assessment, U.S. Environmental Protection Agency, Research Triangle Park, North Carolina, United States. Electronic address: kodavanti.urmila@epa.gov.
Publikováno v:
Toxicology and applied pharmacology [Toxicol Appl Pharmacol] 2021 Mar 15; Vol. 415, pp. 115430. Date of Electronic Publication: 2021 Jan 30.